Clinical trial · Observational
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
NCT06374914CI-TRIAL-00076266unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Studies in the literature are limited both throughout Turkey and in general. For this reason, as a result of the study that we will create, it will provide us with information for bladder protective treatments in patients who do not respond to BCG therapy in bladder cancer patients.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| BCG | — | UNRESOLVED | — |
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Docetaxel | — | UNRESOLVED | — |
| Gemcitabine | — | UNRESOLVED | — |
| Intravesical Instillation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intravesical Solution | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with BCG unresponsiveness and receiving intravesical gemcitabine doxetaxel
- interventionNames
- Drug: Intravesical Solution
- label
- Patients with BCG unresponsiveness and radical cystectomy performed
Primary outcomes (4)
- measure
- Recurrence rate
- timeFrame
- 5 years
- description
- the recurrence rate after intravesical chemotherapy will be calculated
- measure
- Progression rate
- timeFrame
- 5 years
- description
- the progression rate after intravesical chemotherapy will be calculated
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: \- BCG refractory/relapsed/unresponsive or intolerant Who do not want or are not suitable for radical cystectomy Exclusion Criteria: \- BCG naive A history of multiple cancers Having a radical cystectomy plan
References
Publications (0)
Data not yet available
No reference posted for this study.